Improved molecular diagnosis of patients with neonatal diabetes using a combined next-generation sequencing and MS-MLPA approach

References

1. Greeley SA, Tucker SE, Naylor RN, Bell GI, Philipson LH. Neonatal diabetes mellitus: a model for personalized medicine. Trends Endocrin Met 2010;21:464–72.10.1016/j.tem.2010.03.004Search in Google Scholar PubMed PubMed Central

2. Grulich-Henn J, Wagner V, Thon A, Schober E, Marg W, et al. Entities and frequency of neonatal diabetes: data from the diabetes documentation and quality management system (DPV). Diabetic Med 2010;27:709–12.10.1111/j.1464-5491.2010.02965.xSearch in Google Scholar PubMed

3. Iafusco D, Massa O, Pasquino B, Colombo C, Iughetti L, et al. Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births. Acta Diabetol 2012;49:405–8.10.1007/s00592-011-0331-8Search in Google Scholar PubMed PubMed Central

4. Wiedemann B, Schober E, Waldhoer T, Koehle J, Flanagan SE, et al. Incidence of neonatal diabetes in Austria-calculation based on the Austrian Diabetes Register. Pediatr Diabetes 2010;11:18–23.10.1111/j.1399-5448.2009.00530.xSearch in Google Scholar PubMed

5. Metz C, Cave H, Bertrand AM, Deffert C, Gueguen-Giroux B, et al. Neonatal diabetes mellitus: chromosomal analysis in transient and permanent cases. J Pediatr 2002;141:483–9.10.1067/mpd.2002.127089Search in Google Scholar PubMed

6. Gardner RJ, Mackay DJ, Mungall AJ, Polychronakos C, Siebert R, et al. An imprinted locus associated with transient neonatal diabetes mellitus. Hum Mol Genet 2000;9:589–96.10.1093/hmg/9.4.589Search in Google Scholar PubMed

7. Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SE, et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006;355:467–77.10.1056/NEJMoa061759Search in Google Scholar PubMed

8. Sagen JV, Raeder H, Hathout E, Shehadeh N, Gudmundsson K, et al. Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes 2004;53:2713–8.10.2337/diabetes.53.10.2713Search in Google Scholar PubMed

9. Hattersley A, Bruining J, Shield J, Njolstad P, Donaghue KC. The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes 2009;10(Suppl 12):33–42.10.1111/j.1399-5448.2009.00571.xSearch in Google Scholar PubMed

10. Flanagan SE, Patch AM, Mackay DJ, Edghill EL, Gloyn AL, et al. Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. Diabetes 2007;56:1930–7.10.2337/db07-0043Search in Google Scholar PubMed PubMed Central

11. Mackay DJ, Temple IK. Transient neonatal diabetes mellitus type 1. Am J Med Genet C Semin Med Genet 2010;154C:335–42.10.1002/ajmg.c.30272Search in Google Scholar PubMed

12. Kamiya M, Judson H, Okazaki Y, Kusakabe M, Muramatsu M, et al. The cell cycle control gene ZAC/PLAGL1 is imprinted--a strong candidate gene for transient neonatal diabetes. Hum Mol Genet 2000;9:453–60.10.1093/hmg/9.3.453Search in Google Scholar PubMed

13. Arima T, Drewell RA, Oshimura M, Wake N, Surani MA. A novel imprinted gene, HYMAI, is located within an imprinted domain on human chromosome 6 containing ZAC. Genom 2000;67:248–55.10.1006/geno.2000.6266Search in Google Scholar PubMed

14. Varrault A, Bilanges B, Mackay DJ, Basyuk E, Ahr B, et al. Characterization of the methylation-sensitive promoter of the imprinted ZAC gene supports its role in transient neonatal diabetes mellitus. J Biol Chem 2001;276:186536.10.1074/jbc.C100095200Search in Google Scholar PubMed

15. Mackay DJ, Coupe AM, Shield JP, Storr JN, Temple IK, et al. Relaxation of imprinted expression of ZAC and HYMAI in a patient with transient neonatal diabetes mellitus. Hum Genet 2002;110:139–44.10.1007/s00439-001-0671-5Search in Google Scholar PubMed

16. Bonnefond A, Durand E, Sand O, De Graeve F, Gallina S, et al. Molecular diagnosis of neonatal diabetes mellitus using next-generation sequencing of the whole exome. PloS one 2010;5:e13630.10.1371/journal.pone.0013630Search in Google Scholar PubMed PubMed Central

17. Ellard S, Lango Allen H, De Franco E, Flanagan SE, Hysenaj G, et al. Improved genetic testing for monogenic diabetes using targeted next-generation sequencing. Diabetologia 2013;56:1958–63.10.1007/s00125-013-2962-5Search in Google Scholar PubMed PubMed Central

18. Alkorta-Aranburu G, Carmody D, Cheng YW, Nelakuditi V, Ma L, et al. Phenotypic heterogeneity in monogenic diabetes: the clinical and diagnostic utility of a gene panel-based next-generation sequencing approach. Mol Genet Metab 2014;113:315–20.10.1016/j.ymgme.2014.09.007Search in Google Scholar PubMed PubMed Central

19. Dahl F, Gullberg M, Stenberg J, Landegren U, Nilsson M. Multiplex amplification enabled by selective circularization of large sets of genomic DNA fragments. Nucleic Acids Res 2005;33:e71.10.1093/nar/gni070Search in Google Scholar PubMed PubMed Central

20. Berglund EC, Lindqvist CM, Hayat S, Övernäs E, Henriksson N, et al. Accurate detection of subclonal single nucleotide variants in whole genome amplified and pooled cancer samples using HaloPlex target enrichment. BMC Genom 2013;14:856.10.1186/1471-2164-14-856Search in Google Scholar PubMed PubMed Central

21. Alkorta-Aranburu G, Carmody D, Cheng YW, Nelakuditi V, Ma L, et al. Phenotypic heterogeneity in monogenic diabetes: The clinical and diagnostic utility of a gene panel-based next-generation sequencing approach. Mol Genet Metab 2014;113:315–20.10.1016/j.ymgme.2014.09.007Search in Google Scholar PubMed PubMed Central

22. Richards S, Aziz N, Bale S, Bick D, Das S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405–24.10.1038/gim.2015.30Search in Google Scholar PubMed PubMed Central

23. Babenko AP, Polak M, Cave H, Busiah K, Czernichow P, et al. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 2006;355:456–66.10.1056/NEJMoa055068Search in Google Scholar PubMed

24. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004;350:1838–49.10.1056/NEJMoa032922Search in Google Scholar PubMed

25. Støy J, Edghill EL, Flanagan SE, Ye H, Paz VP, et al. Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci U S A 2007;104:15040–4.10.1073/pnas.0707291104Search in Google Scholar PubMed PubMed Central

26. Lopes JE, Torgerson TR, Schubert LA, Anover SD, Ocheltree EL, et al. Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. J Immunol 2006;177:3133–42.10.4049/jimmunol.177.5.3133Search in Google Scholar PubMed

27. Carmody D, Beca FA, Bell CD, Hwang JL, Dickens JT, et al. Role of noninsulin therapies alone or in combination in chromosome 6q24-related transient neonatal diabetes: sulfonylurea improves but does not always normalize insulin secretion. Diabetes Care 2015;38:e86–7.10.2337/dc14-3056Search in Google Scholar PubMed PubMed Central

28. Gardner RJ, Robinson DO, Lamont L, Shield JP, Temple IK. Paternal uniparental disomy of chromosome 6 and transient neonatal diabetes mellitus. Clin Genet 1998;54:522–5.10.1111/j.1399-0004.1998.tb03774.xSearch in Google Scholar PubMed

29. Docherty LE, Poole RL, Mattocks CJ, Lehmann A, Temple IK, et al. Further refinement of the critical minimal genetic region for the imprinting disorder 6q24 transient neonatal diabetes. Diabetologia 2010;53:2347–51.10.1007/s00125-010-1853-2Search in Google Scholar PubMed

30. Mackay DJ, Boonen SE, Clayton-Smith J, Goodship J, Hahnemann JM, et al. A maternal hypomethylation syndrome presenting as transient neonatal diabetes mellitus. Hum Genet 2006;120:262–9.10.1007/s00439-006-0205-2Search in Google Scholar PubMed

31. Mackay DJ, Callaway JL, Marks SM, White HE, Acerini CL, et al. Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57. Nat Genet 2008;40:949–51.10.1038/ng.187Search in Google Scholar

32. Edghill EL, Flanagan SE, Patch AM, Boustred C, Parrish A, et al. Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 2008;57:1034–42.10.2337/db07-1405Search in Google Scholar

33. Edghill EL, Bingham C, Slingerland AS, Minton JA, Noordam C, et al. Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1beta in human pancreatic development. Diabetic Med 2006;23:1301–6.10.1111/j.1464-5491.2006.01999.xSearch in Google Scholar

34. Naylor RN, Greeley SA, Bell GI, Philipson LH. Genetics and pathophysiology of neonatal diabetes mellitus. J Diabetes Investig 2011;2:158–69.10.1111/j.2040-1124.2011.00106.xSearch in Google Scholar

35. De Franco E, Flanagan SE, Houghton JA, Lango Allen H, Mackay DJ, et al. The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study. Lancet 2015;386:957–63.10.1016/S0140-6736(15)60098-8Search in Google Scholar

36. von Mühlendahl KE, Herkenhoff H. Long-term course of neonatal diabetes. N Engl J Med 1995;333:704–8.10.1056/NEJM199509143331105Search in Google Scholar PubMed

37. Massa O, Iafusco D, D’Amato E, Gloyn AL, Hattersley AT, et al. KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes. Hum Mutat 2005;25:22–7.10.1002/humu.20124Search in Google Scholar PubMed

38. Rubio-Cabezas O, Flanagan SE, Damhuis A, Hattersley AT, Ellard S. KATP channel mutations in infants with permanent diabetes diagnosed after 6 months of life. Pediatr Diabetes 2012;13:322–5.10.1111/j.1399-5448.2011.00824.xSearch in Google Scholar PubMed

39. Pearson ER, Flechtner I, Njolstad PR, Malecki MT, Flanagan SE, Larkin B, et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006;355:467–77.10.1056/NEJMoa061759Search in Google Scholar PubMed

40. Rafiq M, Flanagan SE, Patch AM, Shields BM, Ellard S, et al. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care 2008;31:204–9.10.2337/dc07-1785Search in Google Scholar PubMed PubMed Central

41. Sovik O, Aagenaes O, Eide SA, Mackay D, Temple IK, et al. Familial occurrence of neonatal diabetes with duplications in chromosome 6q24: treatment with sulfonylurea and 40-yr follow-up. Pediatric diabetes 2012;13:155–62.10.1111/j.1399-5448.2011.00776.xSearch in Google Scholar PubMed

42. Schimmel U. Long-standing sulfonylurea therapy after pubertal relapse of neonatal diabetes in a case of uniparental paternal isodisomy of chromosome 6. Diabetes Care 2009;32:e9.10.2337/dc08-1813Search in Google Scholar PubMed PubMed Central

43. Stoy J, Greeley SA, Paz VP, Ye H, Pastore AN, et al. Diagnosis and treatment of neonatal diabetes: a United States experience. Pediatr Diabetes 2008;9:450–9.10.1111/j.1399-5448.2008.00433.xSearch in Google Scholar PubMed PubMed Central